{"title":"伊朗南部沿海地区2型糖尿病、肥胖、中枢性肥胖和代谢综合征的患病率:波斯班达尔港队列研究:简要报告","authors":"Ghazal Zoghi, Masoumeh Kheirandish","doi":"10.34172/HMJ.2021.109599","DOIUrl":null,"url":null,"abstract":"Background: There has been no recent estimate of non-communicable diseases (NCDs) in south of Iran. Our data are based on the results of the population-based Bandare Kong Cohort Study, as part of the Prospective Epidemiological Research Studies in IrAN (PERSIAN). Methods: In this cohort, 4063 people aged 35-70 years were recruited from Hormozgan province, South of Iran. Results: We found that the age-standardized prevalence (ASP) of metabolic syndrome (MetS), type 2 diabetes (T2DM), impaired fasting glucose (IFG), obesity, and central obesity in this population were 34.5%, 17.4%, 20.6%, 24.6%, and 44.4%, respectively. Conclusion: These results give a new insight into the prevalence of the NCDs in a sample population from south of Iran and provide the authorities with the necessary information to design guidelines for the control and prevention of these diseases.","PeriodicalId":271947,"journal":{"name":"Hormozgan Medical Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Prevalence of Type 2 Diabetes, Obesity, Central Obesity, and Metabolic Syndrome in a South Coastal Region, Iran, the PERSIAN Bandare Kong Cohort Study: A Brief Report\",\"authors\":\"Ghazal Zoghi, Masoumeh Kheirandish\",\"doi\":\"10.34172/HMJ.2021.109599\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: There has been no recent estimate of non-communicable diseases (NCDs) in south of Iran. Our data are based on the results of the population-based Bandare Kong Cohort Study, as part of the Prospective Epidemiological Research Studies in IrAN (PERSIAN). Methods: In this cohort, 4063 people aged 35-70 years were recruited from Hormozgan province, South of Iran. Results: We found that the age-standardized prevalence (ASP) of metabolic syndrome (MetS), type 2 diabetes (T2DM), impaired fasting glucose (IFG), obesity, and central obesity in this population were 34.5%, 17.4%, 20.6%, 24.6%, and 44.4%, respectively. Conclusion: These results give a new insight into the prevalence of the NCDs in a sample population from south of Iran and provide the authorities with the necessary information to design guidelines for the control and prevention of these diseases.\",\"PeriodicalId\":271947,\"journal\":{\"name\":\"Hormozgan Medical Journal\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-11-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hormozgan Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/HMJ.2021.109599\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormozgan Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/HMJ.2021.109599","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Prevalence of Type 2 Diabetes, Obesity, Central Obesity, and Metabolic Syndrome in a South Coastal Region, Iran, the PERSIAN Bandare Kong Cohort Study: A Brief Report
Background: There has been no recent estimate of non-communicable diseases (NCDs) in south of Iran. Our data are based on the results of the population-based Bandare Kong Cohort Study, as part of the Prospective Epidemiological Research Studies in IrAN (PERSIAN). Methods: In this cohort, 4063 people aged 35-70 years were recruited from Hormozgan province, South of Iran. Results: We found that the age-standardized prevalence (ASP) of metabolic syndrome (MetS), type 2 diabetes (T2DM), impaired fasting glucose (IFG), obesity, and central obesity in this population were 34.5%, 17.4%, 20.6%, 24.6%, and 44.4%, respectively. Conclusion: These results give a new insight into the prevalence of the NCDs in a sample population from south of Iran and provide the authorities with the necessary information to design guidelines for the control and prevention of these diseases.